Allspring Global Investments’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9M | Sell |
214,606
-13,406
| -6% | -$929K | 0.02% | 599 |
|
|
2025
Q1 | $21M | Buy |
228,012
+16,546
| +8% | +$1.52M | 0.04% | 504 |
|
|
2024
Q4 | $10.6M | Sell |
211,466
-39,602
| -16% | -$1.98M | 0.02% | 742 |
|
|
2024
Q3 | $11.6M | Buy |
251,068
+123,720
| +97% | +$5.73M | 0.02% | 719 |
|
|
2024
Q2 | $4.14M | Buy |
127,348
+541
| +0.4% | +$17.6K | 0.01% | 996 |
|
|
2024
Q1 | $3.19M | Buy |
126,807
+58,468
| +86% | +$1.47M | 0.01% | 1066 |
|
|
2023
Q4 | $2.22M | Sell |
68,339
-15,358
| -18% | -$499K | ﹤0.01% | 1152 |
|
|
2023
Q3 | $2.28M | Buy |
83,697
+65,148
| +351% | +$1.77M | ﹤0.01% | 1158 |
|
|
2023
Q2 | $413K | Sell |
18,549
-96,859
| -84% | -$2.16M | ﹤0.01% | 1607 |
|
|
2023
Q1 | $2.5M | Sell |
115,408
-25,120
| -18% | -$544K | ﹤0.01% | 1177 |
|
|
2022
Q4 | $2.85M | Buy |
140,528
+67,462
| +92% | +$1.37M | ﹤0.01% | 1138 |
|
|
2022
Q3 | $1.87M | Buy |
73,066
+57,775
| +378% | +$1.48M | ﹤0.01% | 1250 |
|
|
2022
Q2 | $363K | Sell |
15,291
-71,969
| -82% | -$1.71M | ﹤0.01% | 1659 |
|
|
2022
Q1 | $1.97M | Sell |
87,260
-2,815
| -3% | -$63.4K | ﹤0.01% | 1511 |
|
|
2021
Q4 | $1.78M | Buy |
+90,075
| New | +$1.78M | ﹤0.01% | 1603 |
|